Following on from the success of the inaugural meeting which attracted over 150 key senior attendees, Global Engage is pleased to announce the 2nd Precision Medicine Congress which will be held on 14-15 September 2015 in London, UK. The meeting is part of our successful Drug Discovery series which includes innovative meetings on Digital Health, Digital Pathology, Human Microbiome, Synthetic Biology, qPCR / dPCR, & Biologics among others. www.globalengage.co.uk/events/
Recent advancements in the biomarker, CDx genomic and big data space have meant that some of the fundamental challenges of precision medicine are being realised. The potential for personalized medicine and therefore the possibility of delivering superior outcomes for patients is in reach. There is, however, a lot more to do. Alongside the continued developments in science as well as improvements in clinical trial design, support mechanisms such as market access /reimbursement/ regulatory strategies need to be further developed. Continued work by all stakeholders is therefore vital for success.
The congress has been purposely designed for a variety of audiences from drug and DX developers, payers, healthcare providers, academics to technology solution providers.
Attracting experts working in all areas of precision and personalised medicine such as biomarkers, CDx, translational medicine, clinical trials, genomics, NGS, bioinformatics and health economics, this two day interactive meeting will provide you the opportunity to take home cutting edge strategies, case study examples and methods to allow you to both implement and take the vital next steps in delivering precision medicine. This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, expert led case study presentations and interactive Q&A panel discussions examining topics during four separate tracks covering the areas below.
More information on the event can be found here